Search research articles
Contact Us
Filters
Showing results (361-370 of 443) with videos related to
Page
of 45
Sort By:
Cancer
|
April 23, 2014
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors
David S Hong, Ignacio Garrido-Laguna, Suhendan Ekmekcioglu, et al.
JAMA Network Open
|
June 8, 2019
Deep Learning-Assisted Diagnosis of Cerebral Aneurysms Using the HeadXNet Model
Allison Park, Chris Chute, Pranav Rajpurkar, et al.
JCO Precision Oncology
|
February 20, 2026
Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E
Neal Akhave, Zihe Song, David S Hong, et al.
Cancer Research Communications
|
August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 Unit
Camila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
NPJ Precision Oncology
|
August 6, 2021
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors
Aaron S Mansfield, David S Hong, Christine L Hann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2017
Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers
Lino Möhrmann, Helen J Huang, David S Hong, et al.
NPJ Precision Oncology
|
March 20, 2021
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
Apostolia Maria Tsimberidou, David S Hong, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial
Marcelo V Negrao, Alvaro G Paula, David Molkentine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2020
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
Scott Kopetz, Katherine A Guthrie, Van K Morris, et al.
The New England Journal of Medicine
|
December 22, 2022
Sotorasib in <i>KRAS</i> p.G12C-Mutated Advanced Pancreatic Cancer
John H Strickler, Hironaga Satake, Thomas J George, et al.
Page
of 45
Search research articles
Search
Showing results (361-370 of 443) with videos related to
Sort By:
Page
of 45
Cancer
|
April 23, 2014
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors
David S Hong, Ignacio Garrido-Laguna, Suhendan Ekmekcioglu, et al.
JAMA Network Open
|
June 8, 2019
Deep Learning-Assisted Diagnosis of Cerebral Aneurysms Using the HeadXNet Model
Allison Park, Chris Chute, Pranav Rajpurkar, et al.
JCO Precision Oncology
|
February 20, 2026
Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E
Neal Akhave, Zihe Song, David S Hong, et al.
Cancer Research Communications
|
August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 Unit
Camila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
NPJ Precision Oncology
|
August 6, 2021
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors
Aaron S Mansfield, David S Hong, Christine L Hann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2017
Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers
Lino Möhrmann, Helen J Huang, David S Hong, et al.
NPJ Precision Oncology
|
March 20, 2021
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
Apostolia Maria Tsimberidou, David S Hong, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial
Marcelo V Negrao, Alvaro G Paula, David Molkentine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2020
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
Scott Kopetz, Katherine A Guthrie, Van K Morris, et al.
The New England Journal of Medicine
|
December 22, 2022
Sotorasib in <i>KRAS</i> p.G12C-Mutated Advanced Pancreatic Cancer
John H Strickler, Hironaga Satake, Thomas J George, et al.
Page
of 45